AstraZeneca Pharma India Limited (NSE: ASTRAZEN)

AstraZeneca Pharma India Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 22, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	158,423	133,010	81,183	63,886	75,255	59,789
Market Cap Growth	76.87%	63.84%	27.07%	-15.11%	25.87%	19.68%
Enterprise Value	153,626	127,861	76,552	60,484	72,857	57,477
Last Close Price	6319.85	5310.51	3228.09	2525.57	2976.40	2376.15
PE Ratio	-	82.20	81.28	102.50	79.75	82.27
PS Ratio	13.42	10.27	8.09	7.93	9.25	7.19
PB Ratio	29.32	18.68	13.79	12.49	16.50	16.41
P/TBV Ratio	29.40	18.74	13.79	12.49	16.50	16.41
P/FCF Ratio	2393.80	777.38	163.12	70.07	77.53	81.68
P/OCF Ratio	1180.58	477.25	139.27	63.38	71.82	68.39
EV/Sales Ratio	10.35	9.87	7.63	7.51	8.96	6.91
EV/EBITDA Ratio	97.94	69.81	47.45	73.16	54.94	48.72
EV/EBIT Ratio	112.73	74.58	51.43	87.20	62.67	56.04
EV/FCF Ratio	1846.47	747.29	153.81	66.33	75.06	78.52
Debt / Equity Ratio	0.03	0.01	0.01	0.02	0.03	0.03
Debt / EBITDA Ratio	0.11	0.02	0.04	0.10	0.09	0.10
Debt / FCF Ratio	2.06	0.27	0.14	0.09	0.13	0.16
Asset Turnover	1.27	1.26	1.09	0.99	1.10	1.31
Inventory Turnover	2.54	2.87	2.22	2.11	1.85	2.20
Quick Ratio	1.36	1.89	1.61	1.64	1.46	1.06
Current Ratio	2.25	2.61	2.18	2.12	2.04	1.66
Return on Equity (ROE)	12.28%	24.84%	18.05%	12.73%	22.74%	21.71%
Return on Assets (ROA)	7.27%	10.39%	10.10%	5.31%	9.81%	10.11%
Return on Capital (ROIC)	12.56%	16.33%	16.67%	8.77%	17.21%	18.93%
Earnings Yield	0.52%	1.21%	1.22%	0.96%	1.24%	1.21%
FCF Yield	0.04%	0.13%	0.61%	1.43%	1.29%	1.22%
Dividend Yield	0.00%	0.45%	0.50%	0.40%	0.07%	0.04%
Payout Ratio	73.24%	24.77%	20.14%	8.12%	5.36%	3.46%
Total Shareholder Return	0.03%	0.45%	0.50%	0.40%	0.07%	0.04%

Source: S&P Capital IQ. Standard template. Financial Sources.